TrialCancer biology & therapy2013

Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial.

Jeffrey R Infante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.